10/13/2022
Georg Wolff, MD; Raphael Romano Bruno, MD; Tobias Zeus, MD; Artur Lichtenberg; Malte Kelm, MD; Friedhelm Beyersdorf; Christian Jung, MD, PhD; Christian W. Hamm, MD, PhD, FESC; Jan Gummert, MD, PhD; Andreas M. Zeiher, MD; Magnus Settergren, MD; Amin Polzin, MD; Bernhard Wernly, MD, PhD; Christian Frerker, MD; Raffi Bekeredjian, MD; Timm Bauer, MD; Andreas Beckmann, MD; Sabine Bleiziffer, MD; Stephan M. Ensminger, MD, PhD; Helge Möllmann, MD, PhD; Christopher U. Meduri, MD, MPH; Thomas Walther, MD, PhD; Kari Feldt, MD
We aimed to develop and validate an effective prediction model for 1-year mortality risk in elective transfemoral transcatheter aortic valve replacement (TAVR), ie, the TAVR-Risk (TARI) model.
We aimed to develop and validate an effective prediction model for 1-year mortality risk in elective transfemoral transcatheter aortic valve replacement (TAVR), ie, the TAVR-Risk (TARI) model.
We aimed to develop and validate...